The behind-the-curtain look at how a clinical research site actually runs. Written for people looking to enter the clinical trial world, for new coordinators learning the ropes, and open to anyone curious what happens at clinical research sites.
In this file:
• Why passing screening does not automatically mean a patient is enrolled
• What actually happens the moment someone is enrolled, and who decides it
• Why a site logs every candidate, not just the ones who make it onto the study
• The paperwork that turns “eligible” into “on study”
Last issue, Walter, our invented Study OLS-114 candidate, signed his consent and left with his labs still pending. Coordinator Nani spent the gap building his source documents so that nothing would slow things down if the results cleared. On Monday, they did. Every value was in range. Walter was eligible. He was not, yet, enrolled. Those two words look close enough to trade places. They’re not the same thing, and the space between them is where a lot of the real work of this job lives.
Eligible is not the same as enrolled
Being eligible means a candidate meets the protocol’s criteria on paper. Enrollment is a specific, documented act: someone decides, on the record, that this person is now a subject on the study, and that decision has to be defensible months later to anyone who audits it.
For Study OLS-114, that meant an eligibility confirmation call. Nani read Walter's full eligibility packet, criterion by criterion, to a medical monitor on the sponsor's side, a physician whose job that day was to independently agree that nothing had been missed. It is a second set of eyes on purpose, the same instinct behind a nurse asking a colleague to double check a high-risk medication dose before it goes in. Only after that call confirmed him did Nani move to the next step. This doesn't happen in every case, as the primary responsibility for patient eligibility falls on the primary investigator at the site, but in cases with complex protocol requirements, the medical monitor is a helpful resource to confirm.
What actually happens at enrollment
She logged into the study’s IRT system, the interactive response technology that every site on a trial uses to enroll and randomize patients in real time. She entered Walter’s eligibility data. The system assigned him a subject number and, because Study OLS-114 compares the investigational drug to a placebo, a randomization code that decided which one he would receive. Nani does not know which. Neither does Walter. Neither, for that matter, does Dr. Reyes; that is the blind, and it is what lets the study’s eventual results mean something.
That code is tied to a specific kit number, and that kit number is what tells Lynn, the site pharmacist, exactly which sealed box to pull from the shelf. Randomization does not happen in anyone’s head or in a decision anyone can second-guess later. It happens inside a system, at a specific timestamp, and the system’s record is the only version of events that matters going forward.
Note to File: Coordinators sometimes talk about enrollment like it is a feeling, the moment a patient “starts.” It is not a feeling. It is a system entry, made after an independent confirmation, that creates a permanent record. Treat the moment with exactly that much weight. There is no version of “I enrolled them in my head first and did the paperwork later.” The paperwork is the enrollment.
The candidates who do not make it in
Every site keeps two logs running side by side: a screening log, listing everyone who was ever considered, and an enrollment log, listing only the ones who made it all the way through. Auditors and sponsors look at both, because the gap between them tells its own story. If a site’s screen failure rate is unusually high, or unusually low, that is useful information about how well the criteria are being applied, and it protects the site from any later question about who was quietly steered in or out.
Walter’s file now lived in both logs: screened on one date, enrolled on another, the space between them accounted for in writing.
First dose
Wednesday was Walter’s first dosing visit. Lynn pulled the kit that matched his randomization code, checked it against the log, and dispensed it. Nani ran through the visit’s full schedule of assessments, the same grid she had first met as 118 pages of a protocol she barely understood. Walter asked how long the effect might take to show up. Nani told him the truth: nobody at the site would know before the data was unblinded, possibly not for a long time. He nodded, and said that was fine, he had signed up to help answer that question, not to know the answer first.
Nani wrote the visit up, closed the note, and sat for a second with the fact that a person she had met three weeks ago, sitting in her chair for a screening visit, was now genuinely on a research study because of a chain of confirmed decisions she had helped build, one document at a time.
The takeaway
Eligible and enrolled are not the same word doing double duty. Enrollment is a confirmed, system-recorded decision, not a feeling or a shortcut, and it should never happen anywhere except in that system. Log every candidate, not just the ones who make it in; the gap between the two logs is information, not paperwork for its own sake. And once someone is dosed, the honest answer to “did it work” is often “we do not know yet,” which is not a failure of the process. It is the process working exactly as designed.
Explore more
• Root to Rx: the newsletter and The Root Room, the patient-facing side of the same story, at roottorx.com
• Root to Rx: free Patient Logs at shop.roottorx.com, for anyone tracking their own symptoms the way Walter’s diary tracks his
References
• FDA — E6(R3) Good Clinical Practice, Guidance for Industry (adopted by FDA Sept 9, 2025)
The Open Site File is general education about how clinical research sites work. It is not regulatory, legal, or medical advice, and it is not tied to any specific study, sponsor, or employer. Study OLS-114, Walter, and all names are invented. Always follow your own site’s SOPs, your protocol, and your PI and QA team. Characters are composites.
Filed by Justin Yamashita, MSc., Open Label Media
Next in the file: handling the investigational product. What Lynn actually does behind that locked door, and why a single unexplained number on a drug count becomes everyone’s problem.